DOI: 10.1056/NEJMoa1616011 [Google Scholar] Kaul S
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
We can have a nuanced conversation with the patient about taking the medication, what the benefits are, what the potential risks are, and help them formulate a plan to transition off the medication once theyre ready to start trying to conceive, she says
Frequently asked questions How long should I hold GLP-1 drops under my tongue
As with other microdosing trends, GLP-1 microdosing is expected to increase in popularity, particularly among telehealth providers, according to eMarketer